| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Viking Global Investors LP | 10% Owner | 2025-10-07 | 308,643 | $32.25 | $9.95MSell |
| Viking Global Investors LP | 10% Owner | 2025-10-07 | 16,315 | $32.25 | $526.16kSell |
| Viking Global Investors LP | 10% Owner | 2025-10-07 | 25,042 | $32.25 | $807.60kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Perceptive Advisors LLC | 9.95% | 1,452,707 | $109.35M | Institution |
| Viking Global Investors LP | 9.84% | 1,437,705 | $108.22M | Institution |
| Morgan Stanley | 7.99% | 1,167,728 | $87.89M | Institution |
| Sanofi | 7.93% | 1,157,926 | $87.16M | Institution |
| Inhibrx Inc | 7.93% | 1,157,926 | $87.16M | Insider |
| Jon Faiz Kayyem | 7.25% | 1,059,046 | $79.71M | Insider |
| Mark Lappe | 7.19% | 1,050,413 | $79.06M | Insider |
| Hightower Advisors LLC | 5.96% | 870,507 | $65.52M | Institution |
| Blackrock Inc | 5.32% | 777,383 | $58.51M | Institution |
| Vanguard Group Inc | 4.27% | 623,084 | $46.90M | Institution |